瑞典Halo Genomics AB www.halogenomics.com
Halo公司位于瑞典乌普萨拉科学园，其前身为Olink Genomics公司，专注于为新一代测序平台提供目标基因富集技术，使其在过去两年发展极为迅速。虽然公司雇员不超过20人，但却拥有用于基因测序的PCR核心技术——HaloPlex技术，基于该技术的系统具有可扩展性、灵活性等特点。
2011年Agilent收购Halo Genomics,下一代DNA测序市场的创新技术的供应商

 
 Halo Genomics AB is a provider of high performance products and services for the rapidly expanding market of next-generation DNA sequencing. Based on our proprietary technologies for sequence-selective sample preparation, we offer intelligent, high performance sample preparation solutions in simple and scalable formats that provide scientists with enabling tools to analyze the genetic foundation of disease.

Instead of employing dedicated instrumentation or laborious reaction formats, Halo Genomics has developed HaloPlex PCR - an innovative molecular approach that provides robust and easy-to-use methods for targeted resequencing. The probe libraries that are used with this technology are designed through unique and proprietary software.

The company was founded in 2008 by Olink AB and researchers from Uppsala University, Sweden. The company holds rights to patents and patent applications concerning selective DNA amplification. Halo Genomics is currently funded by private investments and grants. The company is based in Uppsala, Sweden.